Consortium

Our multi-disciplinary consortium brings together outstanding expertise consisting of 6 research institutions with leading scientists in their field, 2 SMEs and 1 NGO with expertise in ethical and social aspects of transplantation.

University of Geneva, Department of Surgery (UNIGE)

The Cell Isolation and Transplantation Center (CITC) at UNIGE comprises a basic research laboratory, located in the Faculty of Medicine
building. The mission of the CITC is to develop innovative therapies for the most severe forms of diabetes.
Role within VANGUARD: UNIGE are the coordinator of the VANGUARD project and focus on the assembly of bioartificial pancreas and the biocompatibility, safety and toxicity. UNIGE also support the activities in the work packages on the generation and evaluation of the insulin-secreting organoids, the pre-clinical developments and outreach and dissemination.

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Department of Health Sciences (UNIUPO)

The School of Medicine of Università del Piemonte Orientale “Amedeo Avogadro“ (UNIUPO) combines the Department of Health Sciences (DHS) and the Department of Translational Medicine in strict collaboration with the top-quality hospital (AOU Maggiore della Carità). The mission of the Department of Health Sciences is to perform cutting-edge science in the field of liver diseases, tumor biology, tissue engineering, gene therapy, genetic and immunology and to promote the translation of basic discoveries into therapeutic advances.
Role within VANGUARD: UNIPO leads together with UNIGE the generation of immunomodulatory human Amniotic Epithelial Cells (hAECs) by gene editing or lentiviral vector-based gene therapy and the isolation of Blood Outgrowth Endothelial Cells (BOECs) to be used for vascularization of bioartificial pancreas.

Lyon Claude Bernard University, Transplantation Department, Edouard Herriot University Hospital (CHU-LYON)

The Transplantation department of Lyon University Hospital (Hospices Civils de Lyon, HCL) have pioneered solid organ transplantation in the beginning of the 20th century and have since maintained a tradition of innovation in this field, among its expertise is the transplantation for diabetic patients. The HCL transplantation department is currently one of the largest transplantation centre in Europe, performing 200 transplantations a year.
Role within VANGUARD: CHU-LYON will co-lead in WP3 “Generation of immunomodulatory human Amniotic Epithelial Cells (hAECs) by genome editing, the functional assessment of bioartificial pancreas and the biocompatibility, safety and toxicity.

IRCCS Ospedale San Raffaele, Diabetes Research Institute (OSR)

OSR integrates basic and clinical research through a translational approach, in which lab discoveries translate quickly into clinical therapies and clinical needs drive basic research. The institute aims at understanding the mechanisms underlying a variety of human diseases and at identifying new targets and therapeutic strategies to treat them.
Role within VANGUARD: OSR lead the functional assessment of bioartificial pancreas in vitro and  in vivo experiments and support the assembly of the bioartificial pancreas.

Ludwig-Maximilians-Universität München, Diabetes Center (LMUM)

The Diabetes Center is part of the Medical Clinic and Policlinic IV, University Hospital LMU (LMUM). It provides high level specialised care for the treatment of patients with type 1 and type 2 diabetes and is involved in many multicentre programmes to study prediabetes, progression to overt diabetes and treatment of diabetes and diabetes associated complications.
Role within VANGUARD: LMUM lead the work package on th generation of chimeric, immunoprotected, vascularized insulin-secreting organoids and deliver significant contributions to the functional assessment of bioartificial pancreas experimentations.

Kugelmeiers AG (KGM)

Kugelmeiers AG was founded in September 2015 as a spin off from the University of Zurich in Switzerland. The company comes from the clinical human islet transplantation program of the University Hospital Zurich for the treatment of Diabetes. The clinical need was the driver for 10 years of research and development to create a platform for future cell transplantation applications. Our first product the Sphericalplate 5D (SP5D) is a patented platform enabling advanced 3D cell culturing with ability to translate into diagnostic and clinical use. 
Role within VANGUARD: within VANGUARD, KGM will lead the pre-clinical development, support the Ethics, Legal and Social Aspects (ELSA) and project partners as Innovation Manager.

European Society for Organ Transplantation, Ethical, Legal and Psychosocial Aspects of organ Transplantation (ESOT-ELPAT)

ESOT is the umbrella organisation under which transplant activities are structured and streamlined in Europe and worldwide. Several Sections & Committees within ESOT represent expert knowledge on the respective organs and specialty fields. ESOT cooperates with many other organisations to structure and streamline transplant activities in Europe. Several Sections and Committees within ESOT represent expert knowledge on the respective organs and speciality fields. One of the sections of ESOT – ELPAT –  brings continuity and progress in European research and dialogue on ”Ethical, Legal and Psychosocial As-pects of organ Transplantation”.
Role within VANGUARD: Within the project, ESOT-ELPAT support the Ethical, Legal and Social Aspects (ELSA) of the project.

accelopment AG (ACCEL)

ACCEL is a Swiss SME that assists research institutions and companies in EU project management and the dissemination and exploi-tation of project results. We are specialised in European research, development and innovation support initiatives, such as Horizon 2020 and the SME focused Eurostars programme.  The two core strands of activities comprehend professional project management support, and the facilitation of dissemination and exploitation of project results. Project management support includes administrative and organisational tasks, financial management and reporting.

Role within VANGUARD: ACCEL leads the work package on Stakeholder engagement, dissemination and exploitation and support UNIGE with the coordination and innovation management.

Erasmus University Medical Center Rotterdam (EMC)

Erasmus MC is the largest medical school in the Netherlands, with about 15,298 employees, 3,600 medical students and 226 PhD graduates in 2018. It offers BSc, MSc and PhD programs to train the next generation of medical practitioners and researchers. The Erasmus MC ranks number one of the top European institution in clinical medicine and number 20 in the world according to the Times Higher Education rankings.

Role within VANGUARD: In VANGUARD, Erasmus MC is in the lead for the Ethical, Legal and Social Aspects (ELSA) of the project.